EU GMP Inspection Readiness Training for Sites In and Outside the EU

Opens with a case from 2014: after US findings at the Ranbaxy Laboratories site in Toansa, India, its EU GMP certificate was suspended, an unannounced international inspection followed, and the certificate was later reinstated once corrective measures were judged sufficient. The second case is the 2018 statement of non-compliance for valsartan made by Zhejiang Huahai at its Chuannan site in Linhai, China. Explains what an inspection leads to: a report, your response, and a GMP certificate or action to protect patients. Introduces JKL Pharma, with tablets and capsules in Mumbai, ceftriaxone vials in Singapore and JKL Pharma Europe in Dublin as importer. Clears up common myths about notice and findings, sets out how the course is organised, and ends with a recap.

What you will be able to do

• Explain what an EU GMP inspection can lead to, from certificate to non-compliance
• Describe how the Toansa and Linhai cases show the stakes for a site
• Explain why readiness means complying every day at every site supplying the EU

Why it matters

A certificate can be suspended in weeks and takes evidence to win back, so daily readiness protects every product you supply.

Practice: Practice: Why EU inspection readiness matters · 3 questions

Starts in Dublin, where JKL Pharma Europe's new managing director asks whether a GMP inspector can really arrive with no notice. Explains Article 111 of Directive 2001/83/EC, which provides for inspections, if necessary unannounced, of manufacturers in the Union and in third countries, including laboratories an authorisation holder uses and holders' premises. Covers the GMP directive's check that operations follow the marketing authorisation, and the duties that come with your authorisation: allowing access at any time and having a Qualified Person who certifies every batch in a register kept available to the authority. Then introduces the Compilation of Union Procedures, which sets out how inspectors plan, run and report inspections. Ends with a recap and what to have in place.

What you will be able to do

• Explain the legal basis for EU GMP inspections, announced or not
• Describe the authorisation holder's duties of access and a Qualified Person
• Explain what the Compilation of Union Procedures covers

Why it matters

Knowing the law that lets inspectors in helps managers set realistic expectations and keep the QP and batch register in order.

Practice: Practice: The legal basis and the Compilation · 3 questions

Opens with JKL Pharma's two sites outside the EU: tablets and a separate penicillin-type capsule block in Mumbai, and ceftriaxone powder for injection in vials in Singapore, which carry different risks under the same quality system. Explains the types of inspection, general GMP and product or process related, either announced or not, and how each competent authority plans inspections as a programme. Shows the planning model that combines intrinsic risk and compliance risk into a rating of A, B or C, with the guidance table for compliance risk and the matrix that sets the frequency of routine inspections. Covers how inspectors prepare from your inspection history, recalls, defects and the databases, and write an inspection plan they may change on the day. Ends with myths and a recap.

What you will be able to do

• Explain the difference between general and product or process related inspections
• Apply the A, B or C risk rating to estimate inspection frequency
• Describe what inspectors review before they arrive

Why it matters

Your last inspection sets your next one, so understanding the risk rating shows where your site's effort pays back.

Practice: Practice: How inspections are planned · 3 questions

Starts with JKL Pharma's sites in Mumbai and Singapore, which are third countries under EU law and supply the EU through JKL Pharma Europe in Dublin, holder of an import authorisation from the Irish authority. Explains that the supervisory authority for a site outside the EU is the one that authorised the importer. Covers how it verifies GMP status product by product: from EEA inspections, information from partners under mutual recognition agreements, or its own inspection, and why inspections more than five years old are not normally considered. Shows a step many companies miss, the importer's own controls of audits, batch testing and Qualified Person certification, and how to keep a distant assessment pack ready using the procedure's annex as a checklist. Ends with myths and a recap.

What you will be able to do

• Identify the supervisory authority for a site outside the EU
• Explain how GMP status is verified, including under mutual recognition agreements
• Prepare a distant assessment pack using the procedure's annex

Why it matters

Distance changes the route, not the standard; knowing who supervises your site helps you contact the right inspectorate early.

Practice: Practice: Sites outside the EU · 3 questions

Opens at JKL Pharma's sterile site in Singapore, where a self-inspection found three months of alert-level environmental monitoring results recorded but never investigated or trended. Explains the legal duty in Article 14 of Directive 2017/1572 and Chapter 9 of the GMP Guide: repeated self-inspections on a pre-arranged programme, examining every area in paragraph 9.1 independently and in detail, with records of findings and actions. Shows how JKL turns Chapter 9 into a cycle, inspecting on the floor and in the files, and how the Singapore site sets its own programme, contrasted with a generic maker in Warsaw where managers inspect their own departments. Covers how inspectors examine your self-inspection system without normally reading the reports, and what the Qualified Person needs. Ends with myths and a recap.

What you will be able to do

• Explain the legal duty for self-inspection under Chapter 9
• Plan a self-inspection programme that covers every area in paragraph 9.1
• Apply independence so people do not inspect their own area

Why it matters

A self-inspection that finds real problems lets you fix them first, before an inspector writes them up.

Practice: Practice: Self-inspection under Chapter 9 · 3 questions

Starts in Mumbai, where JKL's head of quality reads the site master file before sending it to the Irish inspectorate and finds it describes two buildings, names a Qualified Person who left last year and lists products no longer made. Explains what the site master file should contain, in about 25 to 30 pages plus appendices, with an edition, an effective date, a review date and regular review to stay current. Covers how inspectors check your documentation system by examining particular examples, both while documents are in use and after they are compiled into complete batch records. Then shows how to check that operations match your marketing authorisations, including approved variations. Ends with common myths about the site master file and documents, and a recap.

What you will be able to do

• Write and review a site master file that reflects the site as it is
• Explain how inspectors test documents in use and complete batch records
• Check that operations match the marketing authorisation and its variations

Why it matters

Your documents speak before you do; a current site master file sets the right first impression with the inspectorate.

Practice: Practice: The site master file and key records · 3 questions

Opens in Dublin at seven in the morning, when two inspectors from the Irish authority arrive unannounced at JKL Pharma Europe's warehouse and laboratory as the night shift ends, and the site's arrival procedure starts. Explains the opening meeting under the EU procedure on the conduct of inspections: describing your quality system, significant changes since the last inspection, past deficiencies, escorts and a room, prepared in advance so the meeting can start within minutes and normally takes no more than 30 minutes. Covers the plant tour, which often follows the flow of materials from goods-in to released finished goods, includes service areas, and follows the signals inspectors see. Examples come from an importer in Lisbon and a sterile contract maker in Amsterdam. Ends with myths and a recap.

What you will be able to do

• Prepare an arrival plan for inspectors on every shift
• Present the four parts of the opening meeting within its normal length
• Explain how inspectors use signals to direct the plant tour

Why it matters

A short, prepared opening meeting and open doors show inspectors a site in control from the first minutes.

Practice: Practice: Opening meeting and the plant tour · 3 questions

Starts in JKL Pharma Europe's laboratory in Dublin, where an inspector asks an analyst about an out-of-specification assay result and the better answer is to show the investigation record, not a guess from memory. Explains that inspectors are establishing facts: answer what is asked, say when you do not know, and show the record. Covers how inspectors take samples and copies, producing records quickly and completely, never altering them, and keeping a request log so every question and copy is tracked. Then explains the Qualified Person's role: showing how each batch could be certified in the register, with a Qualified Person at an importer in Vienna relying on third-party audits and a client unable to show technical agreements under Annex 16. Ends with myths and a recap.

What you will be able to do

• Answer inspectors' questions with facts and the record, not memory
• Run a request log for documents, copies and samples
• Explain how the Qualified Person shows that each batch could be certified

Why it matters

Showing the record instead of guessing builds trust with inspectors and avoids turning a small gap into a deficiency.

Practice: Practice: Answering, documents and the QP · 3 questions

Opens in Mumbai on the last afternoon of an inspection by the Irish authority, where the final meeting presents one major deficiency on incomplete cleaning records in the penicillin block and four others, including an unlabelled container, logbook gaps and an overdue training record. Explains the final meeting, where facts are preferably agreed and deadlines fixed, and the three classes of deficiency, critical, major and other, as defined in the Union report format, with all deficiencies listed even if corrected at once. Covers commenting on the draft report and writing a response with extent, root cause, corrective and preventive actions and a realistic timetable. Examples come from a packager in Madrid and a tablet maker in Hyderabad with a repeat major deficiency. Ends with myths and a recap.

What you will be able to do

• Classify a deficiency as critical, major or other
• Write an inspection response with extent, root cause, CAPA and timetable
• Explain what triggers compliance management after an inspection

Why it matters

Your response decides the next step; a clear, realistic CAPA plan is what turns deficiencies into a GMP certificate.

Practice: Practice: Deficiencies, the final meeting and your response · 3 questions

Returns to Mumbai, where JKL's response to five deficiencies was accepted and the Irish authority issued a GMP certificate within 90 days and entered it in EudraGMDP, which a new EU customer then checks. Explains how certificates can be restricted in scope, with a marketing authorisation holder in Paris finding a contract maker's certificate restricted to certain rooms, and how long a certificate can be relied on: three years, or up to five if extended. Covers compliance management, statements of non-compliance, urgent measures, and Qualified Persons unable to certify batches from the site, save narrow exceptions, recalling how Toansa's certificate was reinstated. Ends with a readiness plan for every day, for the day itself and for after, a recap and the final exam.

What you will be able to do

• Explain how a GMP certificate is issued, recorded in EudraGMDP and relied on
• Describe what a statement of non-compliance means for batch certification
• Build a readiness plan for every day, the inspection day and after

Why it matters

Customers and authorities check EudraGMDP, so a current certificate and a living readiness plan protect your supply to the EU.

Practice: Practice: Certificates, outcomes and your readiness plan · 3 questions